Ripptide has been formed by the collaboration of two leading academic groups, those of Professor Jim Naismith, University of St Andrews, and Professor Marcel Jaspars, University of Aberdeen, both in Scotland.
The scientific founders have received support from a Scottish Enterprise High Growth Spin-Out grant for proof-of-concept studies and the formation of the company.
Ripptide Pharma Ltd. was founded in September 2015 to commercialise the technological breakthroughs.
- patent application (WO2014/001822) currently in the national phase
- second application submitted to UKPTO in November 2014